Predicting and Preventing Parkinson’s
Atria.org / Health Education / Predicting and Preventing Parkinson’s
Dr. Matthew Stern explores the evolving understanding of Parkinson’s disease, highlighting early non-motor symptoms that could transform diagnosis and treatment. He discusses groundbreaking research on biomarkers and genetics, paving the way for earlier intervention and improved outcomes.
About the episode:
In this episode, neurologist Dr. Matthew Stern explores the complexities of Parkinson's disease, emphasizing the importance of early detection and intervention. He discusses two key non-motor symptoms—hyposmia and REM sleep behavior disorder—that could revolutionize diagnosis and treatment approaches. Dr. Stern also delves into the significance of Lewy bodies and the prodromal phase in understanding the disease's pathology. The episode highlights promising research that may shift Parkinson's diagnosis from purely clinical criteria to include biomarkers and genetic factors, potentially altering the disease trajectory for at-risk individuals.
About the series:
Atria’s Vanguard Symposia is a lecture series where some of the world’s most compelling researchers translate leading-edge science into medicine. In each episode, top experts share breakthrough science about preventive health care, dive deep into headline-grabbing topics, and take you beyond the buzzwords to explain the latest in longevity science. Our show will arm you with practical information and the tools of discernment to cut through the hype and understand what matters most.
Atria Health and Research Institute aims to accelerate a global shift from reactive sick care to proactive, preventive health care. We work at the forefront of science and technology and we believe a collaborative approach to modern medicine can extend healthy life for all.
Read more
What to Know About Psilocybin Therapy for Mental Health
Article
Brain health
Mind body
Proponents of psychedelic drugs have been touting their benefits for various mental health conditions for more than half a century. Now, psilocybin—the active ingredient in so-called magic mushrooms—is getting more attention as real-world and clinical trial evidence shows promising results. The field sees promise in the hallucinogenic drug, but many obstacles remain.
Can a Simple Mineral Protect Against Alzheimer’s?
Article
Longevity
Brain health
The findings are genuinely exciting, but well-controlled human trials—especially using potentially safer forms like lithium orotate—are essential before any medical recommendations can be made. Until then, while lithium shows exciting promise in lab and animal studies, it's not ready for primetime.
The Science of Creatine Supplements
Article
Performance & movement
Brain health
Bone health
Based on the mounting evidence, it appears creatine isn’t just for bodybuilders anymore. For more than two decades, scientists have studied this compound for its potential benefits for increasing muscle mass and preventing muscle loss, among other things. More recent studies have investigated its usefulness in improving memory, and there’s even intriguing, though preliminary, research that creatine may play a role in supporting mental health in people with depression.
Sorry no results match your query